Bausch & Lomb adds two BOD members

ROCHESTER, N.Y. Bausch & Lomb named Kerry Clark and Robert Palmisano to its board of directors.

“We are adding two outstanding business leaders with broad and relevant experience,” stated Gerald Ostrov, chairman and CEO, Bausch & Lomb. “Choices like these help us become better positioned for long-term growth. We welcome [Clark] and [Palmisano] and look forward to benefiting from their unique backgrounds and expertise.”

Clark retired in September 2009 as chairman and CEO of Cardinal Health. Under his leadership, Cardinal Health acquired numerous medical technologies that helped the company expand its service to hospitals, pharmacies and clinicians across the United States. Before his leadership at Cardinal Health, Clark spent more than 30 years at Procter & Gamble, where he last served as vice chairman of the board. Clark is currently a director of Textron, General Mills and Hauser Capital Partners. He holds a bachelor’s degree from Queens University.

Palmisano is the president, CEO and director of ev3 Inc., a global provider of technology for treating peripheral vascular disease and neurovascular diseases. Prior to ev3, Palmisano was president and CEO for IntraLase Corp., which designed and developed laser products for vision correction, until IntraLase was acquired by Advanced Medical Optics, Inc. He also served as president and CEO for pharmaceuticals firm MacroChem Corporation and Summit Autonomous, Inc., a global medical products company later acquired by Alcon, Inc.

Palmisano also has a long history with Bausch & Lomb, holding various executive positions within the company from 1985 to 1996. His last role with Bausch & Lomb was as SVP and president of its eyewear division. He holds a bachelor’s degree from Providence College.